Science Explorer Interactive view Map
Company · Zug · Switzerland

Swedish Orphan Biovitrum (Switzerland)

sobi.com/en/country/switzerlandROR OpenAlex
Research works
4
fractional, all time
Citations
41
10.2 per fractional work
Top-10% rate
6.9%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: Swedish Orphan Biovitrum (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Immunology and Microbiology: 11.95× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 3.89× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.67× its world share, 0 worksChemistryEngineering: 0.17× its world share, 0 worksEngineeringEnvironmental Science: 0.53× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.39× its world share, 0 worksMaterials ScienceHealth Professions: 0.38× its world share, 0 worksHealth ProfessionsMedicine: 3.85× its world share, 1 worksMedicineBusiness, Management and Accounting: 0.72× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.9×. Every wedge is a field page.

Which research topics does Swedish Orphan Biovitrum (Switzerland) publish most on?

By volume in 2022–2025: Autoimmune and Inflammatory Disorders Research, Hemophilia Treatment and Research, Acute Lymphoblastic Leukemia research and Liver Disease and Transplantation.

Autoimmune and Inflammatory Disorders Research: 0 fractional worksHemophilia Treatment and Research: 0 fractional worksAcute Lymphoblastic Leukemia research: 0 fractional worksLiver Disease and Transplantation: 0 fractional worksPlatelet Disorders and T…0Platelet Disorders and Treatments: 0 fractional worksTrauma, Hemostasis, Coagulopathy, Resuscitation: 0 fractional worksBlood transfusion and management: 0 fractional worksMyeloproliferative Neopl…0Myeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksGout, Hyperuricemia, Uric Acid: 0 fractional worksSystemic Lupus Erythematosus Research: 0 fractional works
HematologyPublic Health, Environmental and Occupational HealthHepatologyCritical Care and Intensive Care Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  2. 2 Hemophilia Treatment and Research Hematology 0 works
  3. 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
  4. 4 Liver Disease and Transplantation Hepatology 0 works
  5. 5 Platelet Disorders and Treatments Hematology 0 works
  6. 6 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  7. 7 Blood transfusion and management Biochemistry 0 works
  8. 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  9. 9 Gout, Hyperuricemia, Uric Acid Nephrology 0 works
  10. 10 Systemic Lupus Erythematosus Research Rheumatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.2%not open35.8%

World: 28% of research is openly available.

with international co-authors100.0%

World: 19% is written across borders.

How has Swedish Orphan Biovitrum (Switzerland)'s research output changed?

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Zug

All research institutions in Zug

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.